-

Insights on the Worldwide Myopia and Presbyopia Treatment Market (2019 to 2028) - Featuring Topcon, Alcon & Nidek Among Others - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Global Myopia and Presbyopia Treatment Market Outlook 2028" report has been added to ResearchAndMarkets.com's offering.

The market for myopia and presbyopia treatment is anticipated to grow at a CAGR of 7.45% during the forecast period, i.e., 2021-2028. Further, the market accounted for a value of USD 17,836.74 million in 2019 which is predicted to reach a value of USD 34,058.64 million by the end of 2028.

The market for myopia and presbyopia treatment is segmented on the basis of region into North America, Europe, Asia Pacific, Latin America and Middle East & Africa. The market in North America held the leading share in global market in 2019 and is anticipated to continue this trend and hold the largest share of 36.12% in the market in 2028. This can be attributed to the increase in investments by government and private entities to maintain the highest quality of care offered at healthcare facilities. Myopia and presbyopia treatment market in Europe is primarily driven by the demand of these products by Germany, UK, France and Italy.

The market is anticipated to reach a significantly high market size by 2028 as a result of rising availability of innovative treatment methods, particularly LASIK treatment which create this rise in demand for effective treatment products in the region. The market in Asia Pacific is projected to grow at the highest rate during the forecast period with a CAGR of 8.87% between 2021 and 2028 on account of growing advancements and innovations in the industry in countries such as China, Japan and India. The demand for myopia & presbyopia treatment products in Latin America is estimated to develop gradually over the forecast period and is presently capturing a limited market share in the global market with the market being led by the high demand in Brazil on account of changing consumer behaviour towards preventive health measures.

Some of the key industry leaders in the global myopia and presbyopia treatment market are Topcon Corporation, Alcon, Bausch & Lomb Incorporated, Nidek Co., Ltd., Carl Zeiss AG and Johnson & Johnson Vision.

Key Topics Covered:

1. Introduction

2. Assumptions And Acronyms

3. Research Methodology

4. Executive Summary - Global Myopia & Presbyopia Treatment Market

5. Analysis Of Market Dynamics

5.1. Drivers

5.2. Restraints

5.3. Trends

6. Key Market Opportunities

7. Industry Risk Analysis

7.1. Demand Risk Analysis

7.2. Supply Risk Analysis

8. Regulatory Landscape

9. Impact Of Covid-19 On Myopia & Presbyopia Treatment

10. Myopia & Presbyopia Treatment Market Outlook

10.1. Market Size And Forecast, 2018-2028

10.1.1. By Value (Usd Million)

10.2. Myopia & Presbyopia Treatment Market Segmentation, 2018-2028

10.2.1. By Regions

11. Competitive Structure

11.1. Detailed Overview

11.2. Competitive Benchmarking

11.3. Assessment Of Key Product Offerings

11.4. Analysis Of Growth Strategies

11.5. Key Collaborations And Joint Ventures

11.6. Key Mergers And Acquisitions

11.7. Recent News And Developments

11.8. Key Clients And Partners

11.9. Exhaustive Analysis On Key Financial Indicators

11.10. Company Profiles

12. STRATEGIC RECOMMENDATIONS

Companies Mentioned

  • Topcon Corporation
  • Alcon
  • Bausch & Lomb Incorporated
  • Nidek Co. Ltd.
  • Carl Zeiss AG
  • Johnson & Johnson Vision

For more information about this report visit https://www.researchandmarkets.com/r/q05e3q

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Industry:

Research and Markets


Release Versions

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

Protein Engineering for Pharmaceutical Biotechnology Training Course: Understand How to Advance Therapeutic Development and Industrial Applications (Jan 21st - Jan 22nd, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Protein Engineering for Pharmaceutical Biotechnology Training Course (Jan 21st - Jan 22nd, 2026)" training has been added to ResearchAndMarkets.com's offering. Enhance your knowledge in protein engineering to understand how to advance therapeutic development and industrial applications. Protein-based therapeutics have significantly advanced and created new paradigms in disease treatment. Half of the top ten selling drugs in 2023 were protein-based therapeutics. Pro...

Development of Combination Products: 2 Day Critical Interactions Training Course (Feb 9th - Feb 10th, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Development of Combination Products: Critical Interactions Training Course (Feb 9th - Feb 10th, 2026)" training has been added to ResearchAndMarkets.com's offering. The programme will cover the regulatory strategy to adopt and the relevant aspects of GMP and quality processes, including the data expectations for the CTD. It will also review the key relationships between quality, regulatory, R&D and production. Delegates will find this a comprehensive overview o...

Human Factors and Usability Engineering in the Development of Drug Delivery Products Training Course (Feb 11th - Feb 12th, 2026) - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Human Factors and Usability Engineering in the Development of Drug Delivery Products Training Course (Feb 11th - Feb 12th, 2026)" training has been added to ResearchAndMarkets.com's offering. This two-day workshop has been designed specifically for product developers who want to incorporate human factors testing into their product development or need to provide the regulators with specific usability data for their device to comply with the MDR. The format for the d...
Back to Newsroom